impressive promotion , page-29

Hello,

This is my first post after 6 months of reading, on my favourite little speculative stock, ISN.

I recently read and wanted to bring your attention to this op-ed in the NY Times last week. It reaffirmed the opportunity and synergy between the direction healthcare is taking in America and Isonea's offering...

"...And some hospital systems have started programs to monitor asthmatics and improve their treatment."

http://www.nytimes.com/2012/06/05/opinion/asthma-by-the-numbers.html

Otherwise, though obviously there's an issue of cost, I do wonder if management have considered a share consolidation. Equity is traded for a range of reasons, and at the pointy end small movements in share price have an impact on the market capitalisation that's perhaps not commensurate with the valuation of those running with the stock....

Perhaps wishful thinking, but we are coming up on the end of financial year. I wonder how much selling is tax loss induced.....

Cheers,